BAYZED HEALTH (02609) has announced its interim results for the six months ended June 30, 2026, marking a significant financial turnaround. The healthcare company generated revenue of RMB 585 million, representing a modest year-on-year increase of 1.69%, while achieving a net profit attributable to shareholders of RMB 14.418 million.

This latest performance stands in sharp contrast to the same period last year, when the company recorded a net loss of RMB 27.62 million. The earnings per share for the period came in at RMB 0.01, underscoring the company's return to profitability.

According to the company's official announcement, the revenue growth of approximately 1.7% during the reporting period was primarily attributed to stable business operations across its core segments. The favorable results reflect the company's ongoing efforts to maintain consistent performance in its healthcare services despite a challenging market environment.